Additional information
Yellow Powder
151110-15-5
ACI-020806
191.6-194.8°C
C11H8BrN5
290.12
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
5-Bromo-N-(1H-imidazol-2-yl)quinoxalin-6-amine
5-Bromo-N-1H-imidazol-2-yl-6-quinoxalinamine
4,5-Didehydro Brimonidine





![TOFACITINIB DIMER (25 mg) (1,3-Bis{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-1,3-propanedione)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)